Background: To investigate the current status and trend of Helicobacter pyloriH. pylori antibiotics resistance over 5 years in Nanjing area Then we evaluated the primary and post-treatment antibiotic resistance of H. pylori in Nanjing area.
Background
Helicobacter pylori(H. Pylori) is the major cause of chronic gastritis, peptic ulcers, gastric adenocarcinoma, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and various other digestive system diseases [1] [2] [3] . Eradicating the pathogen is crucial for the prevention and treatment of these diseases [4] .
The eradication of H. Pylori is an important issue in the field of preventive medicine. The Maastricht V consensus Report has recommended that the standard triple therapy should now be avoided in areas where clarithromycin resistance is high (> 15%) [5] . China has a large H. Pylori infected population that exhibits complicated antibiotic resistance features [6] . Several studies have reported antibiotic resistance in some regions of China. For example, 20 to 50% of cases are resistant to clarithromycin [7] [8] . The resistance rate to metronidazole in the southeast coastal province of China was 95.4% [9] . With such high resistance rates, the eradication rate of the standard triple therapy for H. Pylori infection has declined to 80%, which is unacceptable for clinical practice [10] [11] [12] .
Some studies [13] [14] have pointed out that the primary eradication rate of H. Pylori can reach 90% if the appropriate antibiotics are selected according to the local antibiotics resistance of H. Pylori. Therefore, paying attention to the research and monitoring of local antibiotic resistant strains can not only understand the situation of H. Pylori resistance, but also guide clinical medication, overcome the production of antibiotic-resistant strains and improve the radical cure rate. The resistance rate of each of the antibiotics used in the treatment of H. Pylori infection should be determined in each geographical area to guide clinical practice.
Therefore, we performed a survey of H. Pylori antibiotic resistance from July 2017 to December 2019 in Nanjing area and analysed trend of H. Pylori antibiotics resistance over 5 years. In addition, we investigated the primary and post-treatment resistance prevalence to six antibiotics. 
Material and Methods

Patient Details
Antibiotic susceptibility test
Antibiotic susceptibility of the isolated H. pylori strains to 6 antibiotics (amoxicillin, clarithromycin, levofloxacin, furazolidone, tetracycline, and metronidazole) were tested by the agar dilution method. The resistance breakpoints of each antibiotics are referred to previous reports or the Clinical and Laboratory Standards Institute (CLSI) guidelines [15] , H. pylori strain ATCC43504 was included as an antibiotic susceptibility testing quality control. All antibiotic susceptibility tests were conducted at the Institute of Gastroenterology, Nanjing First Hospital, Nanjing Medical University.
Statistical analysis
Data analysis was performed by SPSS 17.0 (IBM SPSS, Chicago, IL,USA). Frequencies and percentages were used to describe the antibiotic resistance rates of H. pylori isolates. The univariate association between each factor was quantified by Fisher's exact test and the chi-square test. A probability value of < 0.05 from a two-tailed test was considered statistically significant.
Results
Overall H. pylori antibiotic resistance
To have some insight into the latest regional resistance of H. pylori to the 6 most frequently used antibiotics, we performed an investigation based on 1533 H. pylori strains from July 2017 to December 2019. The resistance rates to amoxicillin, clarithromycin, levofloxacin, furazolidone, tetracycline, and metronidazole were 2.74%, 47.03%, 33.59%, 0.91%, 0.52% and 80.76%, respectively.
The trend of H . P y l o r i a n t i b i o t i c s r e s i s t a n c e o v e r 5 y e a r s i n N a n j i n g a r e a Our preliminary article [16] showed that the resistance rates to amoxicillin, clarithromycin, levofloxacin, furazolidone, and metronidazole were 7.36%, 29.47%, 14.74%, 5.78%, and 60.53%, respectively, in May 2014 to May 2015. It was a pity that we didn't do the resistance rate to tetracycline at that time. During the past 5 years, metronidazole resistance was increased significantly from ranging from 60.53-80.76%.
Compared with the level of past, the resistance rate of clarithromycin, levofloxacin were significant higher, ranging from 29.47-47.03%, 14.74-33.59%, respectively. Interestingly, compared to the past 5 years, our recent results showed lower resistance rates to amoxicillin (P = 0.000) and furazolidone (P = 0.000). Results are depicted in Table 1 . resistance rates, the post-treatment resistance rates to six antibiotics were higher, clarithromycin and levofloxacin were the most obvious (P = 0.000). Results are depicted in Table 2 . shown a propensity to rapidly acquire resistance to many classes of antibiotics after exposure to those agents in the form of monotherapy. These include the fluoroquinolones, the macrolides, the nitroimidazoles. For these reasons, antibiotic resistance remains the major determinant of treatment outcomes, the success rate of eradication has been seriously limited for the progressive increase in antibiotic resistance [19] . Thus, in order to determine the status of H. pylori resistance and its patterns in patients and reliably select sensitive antibiotics for clinical use, it is necessary to perform an investigation especially in the absence of individualized H. pylori culture and antibiotic susceptibility test in Nanjing area.
Previous studies reported that the resistance rates of H. pylori strains collected by different geographic areas in China were 0.01%-6.8% to amoxicillin, 17.6%-37.5% to clarithromycin, 20.6%-33.5% to levofloxacin, 0.01%-0.1% to furazolidone, 0.01%-5.8% to tetracycline and 60%-70% to metronidazole [9, 15, [20] [21] . Our current data showed that the overall resistance rates of amoxicillin, clarithromycin, levofloxacin, furazolidone, tetracycline, and metronidazole were 2.74%, 47.03%, 33.59%, 0.91%, 0.52% and 80.76%, respectively. Resistance to metronidazole has been observed worldwide and presently occurs quite commonly in several countries. The 80.76% resistant rate of this study from July 2017 to December 2019 is higher than that in the past. The high resistant rate was attributable to previous treatment of gynecologic infection or to the therapy of intestinal parasitic infections, which occur frequently in our country. Our data illustrated that the resistance rate of clarithromycin was 47.03%, whereas it was 29.47% in the period of May 2014 to May 2015. According to Maastricht V consensus, when the resistance rate of H.
pylori to clarithromycin in a certain area exceeds 15%, the triple therapy based on PPI containing clarithromycin should not be used as an empirical eradication program of H.
pylori, and clarithromycin resistance test is recommended. The resistance rate of H. pylori to levofloxacin reported in the our study was higher than the 14.74% that was reported in the period of May 2014 to May 2015. Levofloxacin was also widely used in the treatment of urogenital system and respiratory tract infection, which may be the reason for the high resistance rate. However, the prevalence of resistance to amoxicillin, furazolidone and tetracycline were low. Besides, they were all cheap. Therefore, the three antibiotics were recommended due to a lack of resistance and low cost.
We also found that the resistance rates of H. 
Conclusions
Based on the current research data, the resistance rate of H. pylori to clarithromycin, metronidazole and levofloxacin in Nanjing were high, and they were on the rise. In order to improve the eradication rate of the first treatment as much as possible, it is recommended to select the antibiotics with low resistance rate in Nanjing. For posttreatment eradication patients, clinicians should considered the regional drug resistance rate, personal antibiotic exposure history, economic benefit ratio, adverse drug reactions, drug availability and other aspects. According to the results of antibiotics sensitivity test, the combination of two sensitive antibiotics can achieve high eradication rate, reduce the incidence of adverse reactions, and reduce the secondary resistance rate. It is an effective strategy to cope with the current situation of high resistance rate of H. pylori in Nanjing area.
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